These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16397013)

  • 1. Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection.
    Gadi VK; Nelson JL; Boespflug ND; Guthrie KA; Kuhr CS
    Clin Chem; 2006 Mar; 52(3):379-82. PubMed ID: 16397013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking microchimeric DNA in plasma to diagnose and manage organ transplant rejection.
    Baxter-Lowe LA; Busch MP
    Clin Chem; 2006 Apr; 52(4):559-61. PubMed ID: 16595823
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I.
    DeVito-Haynes LD; Jankowska-Gan E; Sollinger HW; Knechtle SJ; Burlingham WJ
    Hum Immunol; 1994 Jul; 40(3):191-201. PubMed ID: 7960963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.
    Zou J; Duffy B; Slade M; Young AL; Steward N; Hachem R; Mohanakumar T
    Hum Immunol; 2017 Apr; 78(4):342-349. PubMed ID: 28267558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of donor-derived DNA in serum: a new approach of acute rejection diagnosis in a rat kidney transplantation model.
    Martins PN; Mashreghi MF; Reutzel-Selke A; Neuhaus P; Volk HD; Tullius SG; Kotsch K
    Transplant Proc; 2005; 37(1):87-8. PubMed ID: 15808556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients.
    Koelman CA; Vaessen LM; Balk AH; Weimar W; Doxiadis II; Claas FH
    Transpl Immunol; 2000 Mar; 8(1):57-64. PubMed ID: 10834611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of urinary donor-derived DNA in renal transplant recipients with acute rejection.
    Zhang Z; Ohkohchi N; Sakurada M; Mizuno Y; Miyagi S; Satomi S; Yamaguchi M; Okazaki H
    Clin Transplant; 2002; 16 Suppl 8():45-50. PubMed ID: 12464132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of immune response to tissue-restricted self-antigens in simultaneous kidney-pancreas transplant recipients with acute rejection.
    Gunasekaran M; Vachharajani N; Gaut JP; Maw TT; Delos Santos R; Shenoy S; Chapman WC; Wellen J; Mohanakumar T
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28639386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microchimerism and rejection in clinical transplantation.
    Elwood ET; Larsen CP; Maurer DH; Routenberg KL; Neylan JF; Whelchel JD; O'Brien DP; Pearson TC
    Lancet; 1997 May; 349(9062):1358-60. PubMed ID: 9149698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function.
    Adamek M; Opelz G; Klein K; Morath C; Tran TH
    Clin Chem Lab Med; 2016 Jul; 54(7):1147-55. PubMed ID: 26574891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble donor DNA and islet injury after transplantation.
    Gadi VK; Nelson JL; Guthrie KA; Anderson CC; Boespflug ND; Redinger JW; Paul B; Dinyari P; Shapiro AM
    Transplantation; 2011 Sep; 92(5):607-11. PubMed ID: 21747325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of PCR and PCR-SSP for detection of urinary donor-origin DNA in renal transplant recipients with acute rejection.
    Zhang Z; Ohkohchi N; Okazaki H; Guo Y
    Chin Med J (Engl); 2003 Feb; 116(2):191-4. PubMed ID: 12775227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism.
    Sivasai KS; Alevy YG; Duffy BF; Brennan DC; Singer GG; Shenoy S; Lowell JA; Howard T; Mohanakumar T
    Transplantation; 1997 Aug; 64(3):427-32. PubMed ID: 9275108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
    Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
    Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of urine cytology in the diagnosis of allograft rejection after combined pancreas-kidney transplantation.
    Radio SJ; Stratta RJ; Taylor RJ; Linder J
    Transplantation; 1993 Mar; 55(3):509-16. PubMed ID: 8384382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatitis-associated protein: a putative marker for pancreas graft rejection.
    van der Pijl JW; Boonstra JG; Barthellemy S; Smets YF; Hermans J; Bruijn JA; de Fijter JW; Daha MR; Dagorn JC
    Transplantation; 1997 Apr; 63(7):995-1003. PubMed ID: 9112354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
    Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of microchimerism in transplant recipients.
    McDaniel HB; Yang M; Sidner RA; Jindal RM; Sahota A
    Clin Transplant; 1999 Apr; 13(2):187-92. PubMed ID: 10202616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of mismatched donor HLA in kidney transplant recipients with unknown donor HLA phenotypes.
    Kwok J; Chan GS; Lam MF; Yan T; Tang L; Kwong KM; Chan KW; Chan TM
    Clin Transplant; 2010; 24(5):E178-81. PubMed ID: 20384732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.